Harnessing Technology to Address Global Catastrophic Biological Risks
This project is an exploration of extant and emerging technologies that have the potential to radically alter the trajectory of Global Catastrophic Biological Risks (GCBR). Through extensive research and interviews with internationally recognized experts in the field, the Center will identify technologies that, with strategic investment over the next decade, might significantly reduce these severe human, animal and plant infectious disease events that pose a catastrophic risk to humanity.
Traditional approaches to early identification, surveillance, and response in epidemics are often too slow or limited in scope to prevent disease from spreading and having serious consequences for affected populations. Consequently, technological interventions to address GCBRs will need to improve disease detection, surveillance, and characterization, and increase response speed and global response reach to help avoid the emergence and geographic spread and/or reduce severity.
The Center will look for emerging technologies as well as those already in wide use for other purposes but have not yet been directed at the problem of severe infectious disease emergencies. Technologies will be of interest if they address any stage of a GCBR event; however, the project’s primarily focus is identifying technologies that can be applied to mitigate the impact of a severe pandemic once the pandemic is underway.
Project team lead: Crystal Watson, DrPH, MPH; Matthew Watson; Tara Kirk Sell, PhD, MA
Project team: Caitlin Rivers, PhD; Matthew Shearer, MPH; Christopher Hurtado, MHS
Project supported by: Open Philanthropy Project